BCBS Michigan Medical Policy Updates – July 2019

Click here to view the Blue Cross Blue Shield Michigan Medical Policy Updates »

July 2019 BCBS Michigan Medical Policy Updates:

• Actigraphy For Obstructive Sleep Apnea and Sleep Disorders
• Allergy Testing and Immunotherapy
• Alpha  –1 Proteinase Inhibitors
• Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening
• Antigen Leukocyte Antibody Test
• Automated Audiometry
• Benlysta® (belimumab)
• Botulinum Toxin Type B Injection
• Cataract Removal Surgery
• Confocal Laser Endomicroscopy
• Continuous Intraocular Pressure Monitoring
• Corneal Hysteresis Measurement for Glaucoma
• Cranial Orthosis (Helmet or Band Therapy) as a Treatment of Plagiocephaly
• Crizanlizumab  ™ (SEG101)
• Denosumab (Prolia®/Xgeva®)
• Denosumab (Prolia®/Xgeva®)
• Desferal® (deferoxamine)
• Dopamine Transporter Imaging with Single Photon Emission Computed Tomography (DaTscan™)
• Drug Testing of Urine, Oral Fluids and Hair
• Dynamic Posturography
• Electroconvulsive Therapy
• Elzonris™ (tagraxofusp-erzs)
• Endovascular Repair of Iliac Artery Bifurcation
• Endovenous Ablation for the Treatment of Varicose Veins (e.g., ClariVein®, VenaSeal™ Closure System)
• Entyvio® (vedolizumab)
• Erwinaze® (asparaginase Erwinia chrysanthemi)
• EvenityTM (romosozumab-aqqg)
• Ex Vivo Lung Perfusion (EVLP)
• Exondys 51® (eteplirsen
• Exondys 51® (eteplirsen)
• Fasenra  ™ (benralizumab)
• Galectin-3 Testing in the Assessment and Management of Chronic Heart Failure
• Gamifant®  (emapalumab-lzsg intravenous injection)
• General Drug Utilization Management Policy
• Genetic Testing – DNA Based Testing for Adolescent Idiopathic Scoliosis
• Genetic Testing (Single Nucleotide Variants) to Predict Risk of Nonfamilial Breast Cancer
• Genetic Testing for Alpha-Thalassemia
• Genetic Testing for Alzheimer’s Disease
• Genetic Testing for Amyotrophic Lateral Sclerosis
• Genetic Testing for Familial Cutaneous Malignant Melanoma (CDKN2A)
• Genetic Testing for Hereditary Hearing Loss
• Genetic Testing for Heterozygous Familial Hypercholesterolemia
• Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes
• Genetic Testing for Macular Degeneration
• Genetic Testing for Retinal Dystrophies
• Genetic Testing for Rett Syndrome
• Genetic Testing for Tay-Sachs Disease
• Genetic Testing-Expanded Molecular Panel Testing of Cancers to Identify Targeted Therapies
• Genetic Testing-Human Platelet Antigen Genotyping
• Genetic, Molecular and Other Tests-Experimental/Investigational Status
• GiaprezaTM (angiotension II)
• Golodirsen   TM (SRP-4053)
• Hemophilia Class Policy
• Herceptin Hylecta  TM (trastuzumab and hyaluronidase-oysk)
• Infliximab Policy
• Intravenous Bisphosphonates
• Intravitreal Injections for Retinal Conditions
• Khapzory™ (levoleucovorin)
• Krystexxa® (pegloticase)
• Luxturna  TM (voretigene neparvovec-rzyl)
• Medical Specialty Drug Site of Care Optimization
• Medications for Hereditary Angioedema
• Medications for Hereditary Angioedema
• Noninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease
• Trazimera  TM (trastuzumab-qyyp)
• Treatment Guidelines for Pulmonary Arterial Hypertension
• Ultomiris™ (ravulizumab)
• Xolair   ® (omalizumab)
• Zinplava™ (bezlotoxumab)
• Zoladex  ® (goserelin acetate implant)
• Zolgensma®  (onasemnogene abeparvovec)

Click here to view the Blue Cross Blue Shield Michigan Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.